Workflow
Jing Ji Guan Cha Bao
icon
Search documents
?2亿真金白银砸向人形机器人赛道!杭州中试基地揭牌,政企央地联手打通产业化“最后一公里”
Jing Ji Guan Cha Bao· 2025-10-28 03:25
Core Insights - The establishment of the humanoid robot pilot base in Hangzhou marks a significant step in the commercialization of humanoid robots, with a total investment of nearly 200 million yuan [1][2] - The base aims to address the industry's "valley of death" by implementing a dual-track model of "technology validation + scenario landing" [1][2] - The event attracted seven investment institutions and three listed companies, indicating strong financial backing and strategic alliances within the humanoid robot sector [1][3] Group 1: Pilot Base Overview - The humanoid robot pilot base is a collaborative effort between the state-owned China Weapon Industry Group and the local government, located in the core area of the Zhijiang Robot Industry Service Port [2] - The facility spans 15,000 square meters and features a dual-track validation system that includes indoor precision testing and outdoor testing across 1,500 acres of real-world scenarios [2] - This setup aims to overcome technical bottlenecks related to perception accuracy and motion stability that are common in the global industry [2] Group 2: Investment and Strategic Partnerships - Seven investment institutions, including China Guoxin Fund and Zhejiang Chuangtou Group, signed financing agreements, committing not only capital but also resources from the upstream and downstream of the industry chain [3] - Three listed companies, including Xiangyang Changyuan Donggu Industrial Co., Zhejiang Haideman Intelligent Equipment Co., and Fuliwang Precision Electromechanical (China) Co., have formed strategic partnerships to focus on key areas such as core component R&D and supply chain collaboration [4] - The collaboration aims to leverage core advantages from both parties to tackle industry technical challenges and accelerate the iteration and large-scale application of humanoid robot products [4] Group 3: Economic Impact and Future Prospects - Hangzhou is rapidly advancing its humanoid robot industry, with the pilot base expected to link with local digital economy and high-end equipment manufacturing clusters to promote rapid technological iteration [5] - The project benefits from the support of the state-owned China Weapon Industry Group and local government policies, combining both technical and market-oriented approaches [5] - The addition of the pilot base is anticipated to enhance the gathering of resources in the humanoid robot industry chain, facilitating the transition of humanoid robots from laboratories to production lines and everyday life [5]
博伊斯在中国:2013–2025回顾展
Jing Ji Guan Cha Bao· 2025-10-28 03:25
Core Insights - Joseph Beuys is a pivotal figure in 20th-century art, known for concepts like "social sculpture" and "everyone is an artist," which continue to influence contemporary understandings of art [1][2] - The exhibition "Beuys in China: A Retrospective 2013-2025" aims to reflect on the twelve-year relationship between the Haowei Art Museum and Beuys, showcasing the museum's commitment to his work [1][2] Exhibition Details - The retrospective is curated by Du Xiyun and features a collection of materials accumulated over twelve years, including exhibition notes, audience feedback, and media reports [2] - The exhibition will display original works and valuable documents related to Beuys, providing insights into his artistic philosophy [2] - The exhibition runs from November 11, 2023, to August 31, 2026, at the Haowei Art Museum located in Shanghai [3]
北京国际插画动画艺术节:莫比斯经典作品首次亮相中国
Jing Ji Guan Cha Bao· 2025-10-28 03:25
Core Insights - The Beijing International Illustration and Animation Art Festival showcases a diverse range of artistic fields, including illustration, animation, and more, emphasizing the intersection of AI and human creativity [1] Highlights - The festival features the first appearance of Moebius's classic works in China, who is known to have inspired Hayao Miyazaki [1] - Special guest Karlotta Freier, the exclusive illustrator for Hermès, is participating in the event [1] - The Chinese premiere of Wayne Barlow's "Psychopomp" is also a key highlight [1] - The SIGGRAPH ASIA computer animation festival will showcase award-winning short films [1] Exhibition Experience - The event spans a 5,000 square meter artistic space, providing an immersive exhibition experience [1] - Attendees can explore a blend of ancient architecture and contemporary art [1] - Seven categories of art, including illustration, animation, and picture books, are on display [1] Event Details - The festival is named the Beijing International Illustration and Animation Art Festival (BIA) [1] - It runs from October 25 to November 2 [1] - The venue is located at Qunyi Building, Qianmen, Beijing [1]
央视曝光“风水大师”诈骗案细节:用AI编话术精准收割,涉案超4600万元
Jing Ji Guan Cha Bao· 2025-10-28 03:25
Core Viewpoint - The news highlights a fraudulent scheme involving a so-called "feng shui master" who exploited over 1,400 elderly victims, resulting in losses exceeding 46 million yuan through a meticulously designed online scam that utilized AI-generated scripts to manipulate and extract money from vulnerable individuals [1][9]. Group 1: Scam Mechanism - The scam began with victims being lured into watching free feng shui videos, leading them to purchase expensive courses [4][7]. - Victims were then subjected to emotional manipulation, where they were told that their family members were in danger, prompting them to pay high fees for "disaster relief" [3][8]. - The operation was structured in three phases: initial engagement through free content, emotional exploitation by predicting disasters, and finally, the collection of high fees for supposed solutions [7][12]. Group 2: Target Demographics - The majority of victims were elderly individuals, primarily aged between 50 and 65, with over 80% being women [4][5]. - This demographic was particularly vulnerable due to their concerns for family health and safety, making them easy targets for the scammers [5][9]. Group 3: Criminal Organization Structure - The criminal organization operated like a business, with distinct roles for each team member, including a central control department and a compliance team to evade law enforcement [12]. - The "second stage" team, responsible for the most critical part of the scam, had the highest earnings, with employees making over 20,000 yuan monthly, and team leaders earning even more [12]. - The use of AI software to craft detailed scripts for interactions with victims was a key tactic, allowing for a more convincing and tailored approach to each individual [12]. Group 4: Law Enforcement Response - Following investigations, police arrested 92 suspects involved in the scam, with 88 facing criminal charges, and identified a total of 46 million yuan in fraudulent activities [9][10]. - The operation was extensive, with evidence showing that the scammers had created detailed profiles of victims to facilitate targeted fraud [9][10].
今日看点|国新办将举行介绍第八届中国国际进口博览会筹备情况新闻发布会
Jing Ji Guan Cha Bao· 2025-10-28 01:49
Group 1 - The State Council Information Office will hold a press conference to introduce the preparation status of the 8th China International Import Expo [1] - The 2025 China Marine Economy Expo will take place from October 28 to 30 in Shenzhen, with a theme of "Digital Intelligence Deep Blue, Creating the Future," covering an exhibition area of 40,000 square meters [2] - A total of 46.65 billion yuan worth of restricted shares will be unlocked today, with 3 companies involved and a total of 102 million shares released [2] Group 2 - 20 companies have disclosed their stock repurchase progress, with 7 companies announcing new repurchase plans and 13 companies completing their repurchase schemes [3] - The highest proposed repurchase amounts are from Yangnong Chemical, Southern Pump Industry, and Yingjie Electric, with plans not exceeding 2.7474 million yuan, 1.165 million yuan, and 871,700 yuan respectively [3] - The companies that have completed the highest repurchase amounts include Liugong, Hefeng Shares, and Mannesmann, with completed repurchases of 400 million yuan, 145 million yuan, and 101 million yuan respectively [3]
乌镇戏剧节落下帷幕,德国大戏引观剧高潮
Jing Ji Guan Cha Bao· 2025-10-27 17:11
Core Insights - The 12th Wuzhen Theatre Festival concluded on October 26, 2025, featuring 25 invited performances and 437 performers, highlighting the festival's role as a significant cultural event in Wuzhen [1] - The festival included a youth competition with 18 groups and 86 young theatre artists, showcasing the commitment to nurturing new talent in the theatre industry [1] Group 1: Awards and Recognitions - The Best Drama Award was won by "Lost in the Garden," which creatively blended themes of ancient dreams and contemporary issues [2] - The Special Attention Award went to "One Dollar," recognized for its heartfelt narrative on family and personal growth [2] - Liu Yuantao and Zhang Jinyang received the Best Individual Performance Award for "Sir, Black is Not Sunshine," which provoked deep reflections on art and social reality [2] Group 2: Major Productions - A highlight of the festival was the "City of Humanity Marathon Play," a 9-hour production by renowned German director Karin Beier and playwright Roland Schimmelpfennig, performed over two rounds with over 10,000 attendees [3] - This production reinterpreted ancient Greek tragedy through a contemporary lens, addressing timeless questions about human society [3] Group 3: Discussions and Future Events - The festival featured 10 dialogues covering various topics such as youth theatre development, the differences between stage and film performance, and the power of female creativity [4] - The 13th Wuzhen Theatre Festival is scheduled for October 15-25, 2026, with the theme "Distant and Profound," reflecting a pursuit of aesthetic beauty rooted in Chinese literary spirit [4]
“十五五”规划蕴含哪些资本市场改革密码?
Jing Ji Guan Cha Bao· 2025-10-27 14:38
Core Insights - The 20th Central Committee's Fourth Plenary Session has concluded, focusing on the formulation of the 15th Five-Year Plan, which will have profound impacts on China's and the global economy, with the capital market playing a more significant role during this period [1] Group 1: Capital Market Development - The capital market during the 15th Five-Year Plan aims to promote high-quality economic development, drive technological innovation, and enhance wealth for residents and society [2] - Reform and opening-up are identified as the two main lines for the development of China's capital market, emphasizing the importance of the capital market in economic and social development [2] - The capital market's core functions extend beyond financing to include incentive mechanisms and wealth management, which are essential for broader economic participation [2] Group 2: Market Growth Potential - The capital market is expected to grow from 100 trillion to 200 trillion yuan during the 15th Five-Year Plan, driven by a shift in asset allocation from real estate to stocks and funds [3] - The traditional economic growth model, reliant on real estate and infrastructure, is reaching its limits, necessitating a new engine based on "technology × capital" for sustainable growth [3] - Recent market trends show stock indices rising despite traditional economic data not exceeding expectations, indicating a shift in how the capital market perceives economic fundamentals [3][4] Group 3: Innovation and Risk Management - The capital market must adapt to price and underwrite innovation risks, which differ significantly from the predictable risks of the industrial era [6] - Current financial systems show weaknesses in recognizing and managing innovation risks, necessitating reforms to enhance tolerance for failure and support diverse financial and technological innovations [7] - The need for a robust mechanism to support innovation failures, such as improved bankruptcy laws and social safety nets, is emphasized to foster a more innovative environment [7] Group 4: Economic Confidence and Policy Directions - Despite external trade tensions and internal economic slowdowns, confidence in the economy and capital markets has significantly improved, driven by policy, corporate, and funding awakenings [8] - The upcoming 15th Five-Year Plan is expected to detail industry and technology policies, focusing on economic rebalancing and social security [8] - Key directions for breaking through during the 15th Five-Year Plan include adjusting performance assessments to prioritize consumption and service sectors, and reforming the fiscal system to reduce reliance on turnover taxes [9] Group 5: Internationalization and Openness - The strategic importance of "high-level opening up" has been elevated in the 15th Five-Year Plan, indicating a shift towards a more reciprocal international capital market [10] - The focus on dual-direction connectivity in capital markets aims to attract international capital while facilitating domestic enterprises' access to global markets [10] - Achieving breakthroughs in foreign investment access and optimizing listing systems could enhance China's capital market's internationalization and resource allocation efficiency [10]
中国药促会宋瑞霖:如果手机价格被管控 就不会有今天的华为
Jing Ji Guan Cha Bao· 2025-10-27 09:50
Core Viewpoint - The key to the pharmaceutical industry's growth in China lies in improving market mechanisms, as highlighted by the comparison with successful companies like Huawei and BYD in other sectors [1]. Group 1: International Comparisons - The U.S. has successfully attracted significant investments from major pharmaceutical companies by establishing price benchmarks and tariff threats, with 60% of their profits coming from the U.S. market [1]. - In contrast, Europe’s social welfare policies have led to a "decentralization" of the pharmaceutical industry, with major companies like Roche and Novartis choosing to launch new drugs in the U.S. due to its larger and more attractive market [1][2]. - The UK's exit from the EU has resulted in reduced market attractiveness, causing large pharmaceutical companies to reconsider their investments [1]. Group 2: Current State of China's Pharmaceutical Industry - China's innovation drug industry is currently mismatched with its market potential, as evidenced by the low per capita spending on innovative drugs compared to Japan, where per capita spending is 24.4 times higher despite a GDP that is only 3.9 times greater [2]. - The pricing logic for innovative drugs differs significantly between China and the U.S., with China initiating price negotiations at the outset, leading to immediate price reductions upon market entry [2]. Group 3: Challenges in Commercialization - While China excels in the invention and transformation stages of the pharmaceutical chain, it struggles in the commercialization phase, often acting merely as a "project provider" due to insufficient market support [3]. Group 4: Recommendations for Improvement - Two core recommendations were proposed: 1. Reform the entry and evaluation mechanisms for innovative drug insurance, suggesting a direct connection between drug approval and insurance coverage, with a two-year evaluation period based on real-world data [4]. 2. Develop commercial health insurance significantly, with a proposed model that could generate over 3.4 trillion yuan annually if 350 million middle-class individuals contribute 800 yuan monthly [5]. Group 5: Economic Impact - If China's innovative drug payment system could reach the level of Japan's, the pharmaceutical industry could become a true economic pillar, allowing companies to pay more taxes and better support public welfare [5].
中国工程院院士曹雪涛:新一轮“创新药国家重大专项”有四大转变
Jing Ji Guan Cha Bao· 2025-10-27 09:50
Core Insights - The new round of the "National Major Special Project for Innovative Drugs" aims to address significant unmet clinical needs in China, focusing on major chronic diseases, infectious diseases, pediatric medications, rare diseases, and special scenario medications [1][3] Group 1: Current Challenges in China's Innovative Drug Development - There are six major challenges facing China's innovative drug development, including urgent medication needs for chronic and infectious diseases, imbalances in disease spectrum matching, weak original innovation capabilities, concentrated research efforts, insufficient international clinical research layout, and the need for improved collaboration among national strategic scientific forces [1] - The "two major and three special" categories refer to major chronic diseases (such as cardiovascular diseases, tumors, metabolic diseases, and neurodegenerative diseases) and specific medication needs for children and rare diseases [1][2] - There are currently 85 rare diseases globally without available treatments, and 62 drugs that exist abroad but are lacking in China, indicating a need for targeted research and development [2] Group 2: Key Transformations in the New Project - The new project will shift from a product-oriented approach to a capability-oriented approach, focusing on the integrated development of varieties, talent, and platforms to enhance sustainable research and development capabilities [3] - There will be a transition from emphasizing the mid-to-lower reaches of the industrial chain to focusing on the upstream innovation chain, prioritizing new targets, mechanisms, and theories to develop original research drugs [3] - The project will no longer support generic drug development and will instead concentrate on original innovative drug research, aligning with unmet clinical needs [3] Group 3: Historical Context and Future Aspirations - The journey of innovative drug development in China has been gradual, driven by continuous national strategic support, evolving from a focus on generic drugs to leading original drug creation [4] - The goal is to overcome significant core technological challenges and produce high-level innovative drugs, ultimately cultivating a group of internationally influential pharmaceutical companies and establishing China as a global center for new drug creation and a hub for the biopharmaceutical industry [4]
昆明丑小鸭中学校长詹大年:学生厌学的根源是教育停留在过时的“行为主义”
Jing Ji Guan Cha Bao· 2025-10-27 09:50
Core Insights - The root cause of students' aversion to school is not the learning itself but the discomfort and fear stemming from various relationships within the school environment, including teacher-student, peer, and parent-child dynamics [2][3] - The educational system is largely stuck in outdated "behaviorism," focusing on rote memorization and knowledge transmission while neglecting higher-order learning methods [2][3] - The increasing prevalence of mental health issues among students is alarming, with approximately 14.8% of a sample from Tsinghua University's study showing varying degrees of depression risk [2][3] Group 1 - The experiences of students like Yixin, who resort to feigning illness to escape academic pressure, highlight a broader issue of academic stress affecting many students at Chou Xiaoyang Middle School [1] - Chou Xiaoyang Middle School, founded in 2011, has successfully helped over 3,000 students who faced issues like depression and anxiety return to a normal state of life [1] - The school adopts a unique approach by not having a fixed library, allowing for creative expression on walls, and co-creating rules with students, emphasizing a safe and warm environment for learning [3] Group 2 - The phenomenon of "four noes" among adolescents—lack of motivation for learning, disinterest in the real world, social incapacity, and feelings of meaninglessness—poses significant challenges for education [3] - The key to addressing students' aversion to school lies in distinguishing whether they dislike all forms of learning or just the current educational practices, which are often rigid and uninspiring [3] - The need for a more compassionate and respectful learning environment is emphasized, where meaningful interactions can foster genuine interest in learning [3]